The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 240.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 20.00 (8.333%)
Open: 250.00
High: 250.00
Low: 250.00
Prev. Close: 250.00
MAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jan 2023 15:33

RNS Number : 3156N
Maintel Holdings PLC
19 January 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR

Maintel Holdings Plc

("Maintel", the "Company" or the "Group")

Trading update for the 12-month period ended 31 December 2022

Maintel Holdings plc (the "Company", the "Group" or "Maintel") announces the following trading update for the financial year ended 31 December 2022 (FY22), based on unaudited financial information.

Group Revenue for the second half of FY22 is expected to be broadly in line with the first half of FY22, delivering approximately £91m of revenue for FY22. However, Adjusted EBITDA* has been negatively affected especially in the 4th Quarter, with Adjusted EBITDA for the year set to be above £4m, due to unexpected inflation costs on 3rd party vendor suppliers, professional services margin reduction due to project delays whilst having to maintain the associated cost base, increased office service costs and lower gross margin on technology sales.

Despite the challenging trading environment with global supply chain issues, a lower volume of public sector tenders and the economic downturn, the Group has built a total sales order backlog exceeding £45m of orders, all of which is under contract and with the project management teams in place for delivery, which will positively impact revenues and associated gross margin levels, especially on professional services in 2023 and beyond as the associated revenue is recognised.

The Company remained cash generative in the period and has reduced its net cash debt** position from £19.4m as at 31 December 2021 to £16.7m as at 31 December 2022, outperforming our expectations, despite Adjusted* EBITDA being below expected levels.

Maintel's transition to a cloud and managed services business continues apace with the Group nearing 170,000 contracted cloud seats at period end, up around 27% from 31 December 2021. The Group's cloud portfolio continues to be enhanced with both Public and Private cloud solutions, with enhanced offerings around Customer Experience.

Commenting on the Group's performance, Chief Executive Officer, Ioan MacRae, said:

"As the pandemic subsides, continuing global hardware supply chain disruptions and inflationary pressures have impacted 2022 performance despite resilient customer demand as evidenced by the sales order backlog standing at an all time high, guaranteeing increased revenue in 2023 and beyond. We have continued to invest in the development of the ICON cloud platform and further enhanced our wider product portfolio to continue to scale our business.  

In light of the disappointing second half EBITDA, the management team is in constructive conversations with its principal banking partner whilst implementing a program of revenue maximisation and process efficiency measures which not only recover Gross Margin performance after the economic headwinds of FY22, but also generate much improved EBITDA and cash generation which will recover to at least recent historical levels.

 

These actions, along with focused positioning of products and services into high growth market segments, support a return to growth in FY23. With the sales order book backlog unwind, continued cloud seat growth and c.73% of recurring revenue flowing into FY23, the Group has improved visibility of revenue generation, gross margin and faster re-alignment of overheads. This supports a substantially improved Adjusted EBITDA outlook for this financial year."

 

 *   Adjusted EBITDA is earnings before interest, tax, depreciation and amortisation, adjusted for share-based payments and exceptional costs.

** Net Cash Debt excludes IFRS16 lease liabilities

For further information please contact:

 

Maintel Holdings Plc

Ioan MacRae, Chief Executive Officer

Gab Pirona, Chief Financial Officer

Dan Davies, Chief Technology Officer

 

0344 871 1122

finnCap, (Nomad and Broker) Jonny Franklin-Adams / Emily Watts (Corporate Finance)

Sunila de Silva (Corporate Broking)

 

020 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVELLIALIV
Date   Source Headline
11th Mar 20082:45 pmRNSHolding(s) in Company
29th Feb 20083:52 pmRNSDirector/PDMR Shareholding
1st Feb 20081:50 pmRNSDirector/PDMR Shareholding
31st Jan 200811:46 amRNSTotal Voting Rights
17th Jan 20089:21 amRNSTransaction in Own Shares
3rd Jan 20083:42 pmRNSDirector/PDMR Shareholding
31st Dec 20077:00 amRNSTotal Voting Rights
10th Dec 200710:16 amRNSTransaction in Own Shares
3rd Dec 20072:16 pmRNSDirector/PDMR Shareholding
1st Nov 20079:07 amRNSDirector/PDMR Shareholding
1st Oct 20072:37 pmRNSDirector/PDMR Shareholding
10th Sep 20077:01 amRNSInterim Results
3rd Sep 200712:48 pmRNSDirector/PDMR Shareholding
8th Aug 20073:10 pmRNSAIM Rule 26
3rd Aug 200711:56 amRNSAcquisition
1st Aug 20074:27 pmRNSDirector/PDMR Shareholding
2nd Jul 200711:45 amRNSDirector/PDMR Shareholding
31st May 200712:29 pmRNSDirector/PDMR Shareholding
30th Apr 20073:27 pmRNSDirector/PDMR Shareholding
25th Apr 20073:37 pmRNSDirector/PDMR Shareholding
2nd Apr 200710:53 amRNSDirector/PDMR Shareholding
28th Mar 20073:16 pmRNSHolding(s) in Company
12th Mar 20077:01 amRNSFinal Results
1st Mar 20079:30 amRNSDirector/PDMR Shareholding
1st Feb 200712:05 pmRNSDirector/PDMR Shareholding
26th Jan 20073:59 pmRNSHolding(s) in Company
22nd Jan 20077:01 amRNSHolding(s) in Company
3rd Jan 200712:46 pmRNSDirector/PDMR Shareholding
22nd Dec 200611:40 amRNSTotal Voting Rights
30th Nov 20063:41 pmRNSDirector/PDMR Shareholding
4th Oct 20067:00 amRNSHolding(s) in Company
28th Sep 20067:01 amRNSTransaction in Own Shares
11th Sep 20067:01 amRNSTransaction in Own Shares
7th Sep 20067:01 amRNSInterim Results
20th Jun 20061:41 pmRNSHolding(s) in Company
13th Jun 200610:18 amRNSTransaction in Own Shares
12th Jun 20061:30 pmRNSAcquisition
13th Mar 20067:01 amRNSFinal Results
22nd Feb 20067:01 amRNSContract Win
10th Jan 20069:23 amRNSDirector/PDMR Shareholding
21st Dec 20052:51 pmRNSDirector/PDMR Shareholding
20th Dec 20055:07 pmRNSDirectorate Change
16th Nov 200512:35 pmRNSTransaction in Own Shares
21st Oct 20055:38 pmRNSTransaction in Own Shrs-Amend
17th Jun 20053:21 pmRNSHolding(s) in Company
25th May 20059:02 amRNSTransaction in Own Shares
4th May 20055:54 pmRNSTransaction in Own Shares
3rd May 20055:31 pmRNSTransaction in Own Shares
11th Mar 20057:00 amRNSFinal Results
19th Jan 20054:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.